DV Q1 2026 Earnings EPS Misses Estimates Amid Competitive Landscape FKWL Q1 2026 Earnings Significant EPS Miss and Stock Decline CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics OLMA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues SHC Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback CIMP Q1 2026 Earnings EPS Surpasses Estimates Amid Stable Performance